There are some chemical structures that are expected to be useful for drug discovery among chemical structures that have not yet been utilized in drug discovery research.

There are two major problems in unutilized chemical structures.

1. Synthesis is complex, or it has never been successfully synthesized.
2. The drug profile (e.g., effect and safety) is unknown when it is applied for drug discovery.

Along with my daily work in a pharmaceutical company, I led a team to develop the new medicinal chemistry platform HiSAP^🄬 by organizing and unifying these unutilized structures for pharmaceutical applications. HiSAP^🄬 is composed of unique synthetic materials (patented or undisclosed) and an original compound-design support system. Compounds that are problematic as drugs can be improved quickly with HiSAP^🄬 and altered into new drug candidates. This reminds one of an alchemist turning base metals into precious metals, and that is why the company is named Alchemedicine (alchemist + medicine).

We continue to value flexible thinking, along with HiSAP^🄬 technology. We are working proactively to create new drugs for areas and diseases that at first seem very difficult for drug discovery. In addition to our internal drug discovery, we are promoting joint drug discovery in cooperation with hospitals, pharmaceutical companies, academia, and other organizations to deliver useful medicines to patients at the earliest.